At a glance

ClinicalIndex Comparison Record

N/ACompleted· 79 enrolled

Drug / intervention

Glue (Dermabond®; Ethicon, Somerville, NJ). +1 moreprocedure

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04371549

NCT04371549N/ACompleted

Compare CT.gov

Skin Closures at Cesarean Delivery, Glue vs Subcuticular Sutures: A Randomized Clinical Trial

Ain Shams Maternity Hospital·interventional·Posted May 1, 2020·Updated Nov 22, 2022

In Brief

A clinical study evaluating Glue (Dermabond®; Ethicon, Somerville, NJ). and Monocryl for Cesarean Wound; Dehiscence. Completed, enrolled 79 participants across 1 site.

Detailed Summary

The optimal choice of skin closure at cesarean delivery has not yet been determined. This study will compare wound complications and scar healing following cesarean delivery between 2 methods of skin closure: glue (Dermabond®; Ethicon, Somerville, NJ) and monofilament (Monocryl®; Ethicon) epidermal sutures.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsCesarean Wound; Dehiscence

CountriesEgypt

Collaborators--

Timeline

N/ACompletedFinished

202120222023202420252026

First PostedMay 2020

Enrollment StartAug 2020

Primary CompletionJan 2021

Study CompletionMar 2021

TodayJul 2026

First PostedMay 1, 2020

Enrollment StartAug 25, 2020

Primary CompletionJan 31, 2021

Study CompletionMar 1, 2021

TodayJul 2, 2026

Enrollment to primary: 5 monthsPosted 6.2 years ago

Interventions

Glue (Dermabond®; Ethicon, Somerville, NJ).procedure

Arm 1: Skin after cesarean section will be closed by glue

Monocrylprocedure

Arm 2: Skin after cesarean section will be closed by running subcuticular sutures using synthetic absorbable monofilament